2-(5-Bromopyridin-3-yl)-4-hydrazinylpyrimidine

Catalog No.: 
ACRTYF127
CAS No.: 
1511149-76-0
Molecular Formula: 
C9H8BrN5
Molecular Weight: 
266.10
2-(5-Bromopyridin-3-yl)-4-hydrazinylpyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$299.00InquiryInquiry
1g95%$855.00InquiryInquiry
5g95%$4190.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(5-Bromopyridin-3-yl)-4-hydrazinylpyrimidine
IUPAC Name2-(5-bromopyridin-3-yl)-4-hydrazineylpyrimidine
MDL No.MFCD23853767
Molecular FormulaC9H8BrN5
Molecular Weight266.10
SMILESNNC1=NC(C2=CC(Br)=CN=C2)=NC=C1
InChI KeySSAXUIWCHIZTSO-UHFFFAOYSA-N
SynonymPyrimidine, 2-(5-bromo-3-pyridinyl)-4-hydrazinyl-
CAS No.1511149-76-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACRTYF127 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHZYR128 route compound structure diagram
    ACHZYR128625-92-3
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRTYF127 route product structure diagram
    ACRTYF1271511149-76-0
Inquiry

2. ACRTYF127 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRTYF127 route product structure diagram
    ACRTYF1271511149-76-0
Inquiry

3. ACRTYF127 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRTYF127 route product structure diagram
    ACRTYF1271511149-76-0
Inquiry

Comments (0)